A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad205 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Guodong Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Ebola, Ebolavirus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Public Health Agency of Canada, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Filoviruses, including ebolaviruses and marburgviruses, can cause severe and often fatal disease in humans. Over the past several years, antibody therapy has emerged as a promising strategy for the treatment of filovirus disease. Here, we describe 2 distinct cross-reactive monoclonal antibodies (mAbs) isolated from mice immunized with recombinant vesicular stomatitis virus–based filovirus vaccines. Both mAbs recognized the glycoproteins of multiple different ebolaviruses and exhibited broad but differential in vitro neutralization activities against these viruses. By themselves, each mAb provided partial to full protection against Ebola virus in mice, and in combination, the mAbs provided 100% protection against Sudan virus challenge in guinea pigs. This study identified novel mAbs that were elicited through immunization and able to provide protection from ebolavirus infection, thus enriching the pool of candidate therapeutics for treating Ebola disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
ORCID-Profile: Logan Banadyga
Förderung
- NIAID NIH HHS
- Public Health Agency of Canada
- National Institute of Allergy and Infectious Diseases
- NIH
Zitieren
APA
Liu, G., He, S., Chan, M., Zhang, Z., Schulz, H., Cao, W., Rahim, M. N., Audet, J., Garnett, L., Wec, A., Chandran, K., Qiu, X., & Banadyga, L. (2023). A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad205
Vancouver
Liu G, He S, Chan M, Zhang Z, Schulz H, Cao W, et al. A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad205
BibTeX
@article{Liu2023,
author = {Liu, Guodong and He, Shihua and Chan, Michael and Zhang, Zirui and Schulz, Helene and Cao, Wenguang and Rahim, Md Niaz and Audet, Jonathan and Garnett, Lauren and Wec, Anna and Chandran, Kartik and Qiu, Xiangguo and Banadyga, Logan},
title = {A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad205}
}
EUVIMED